Wuhan YZY Biopharma Cash Flow Statement

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	-78.04	-97.6	-191.7	-188.87	-148.52
Depreciation & Amortization	5.38	6.57	7.32	6.94	7.62
Loss (Gain) From Sale of Assets	0.07	0.07	0.02	0	0.55
Loss (Gain) From Sale of Investments	-	-	-1.61	-0.67	-1.26
Stock-Based Compensation	0.48	0.48	-	1.58	39.65
Other Operating Activities	51.56	-0.45	3.26	2.19	14.81
Change in Inventory	1.51	1.51	4.85	-1.71	-0.52
Change in Accounts Payable	7.03	7.03	12.52	9.47	0.45
Change in Unearned Revenue	20.44	20.44	-2.34	1.8	0.25
Change in Other Net Operating Assets	-38.77	-38.77	-18.34	-7.44	-11.73
Operating Cash Flow	-30.34	-100.72	-186.02	-176.7	-98.71
Capital Expenditures	-0.78	-1.51	-1.93	-1.41	-1.9
Sale of Property, Plant & Equipment	-	-	-	-	0.05
Investment in Securities	-	-	48.61	-26.83	-18.24
Other Investing Activities	0.91	-3.16	8.13	34.04	0.16
Investing Cash Flow	0.13	-4.67	54.81	5.8	-19.93
Short-Term Debt Issued	-	129.4	89.5	76.5	28
Total Debt Issued	119.3	129.4	89.5	76.5	28
Short-Term Debt Repaid	-	-92	-76.5	-28	-92.07
Long-Term Debt Repaid	-	-0.3	-0.78	-0.44	-0.41
Total Debt Repaid	-82.77	-92.3	-77.28	-28.44	-92.48
Net Debt Issued (Repaid)	36.53	37.1	12.22	48.06	-64.48
Issuance of Common Stock	-	-	173.96	200	149.91
Other Financing Activities	-4.43	-4.08	-9.88	-6.73	-4.4
Financing Cash Flow	32.1	33.02	176.29	241.33	81.03
Foreign Exchange Rate Adjustments	2.44	1.95	-1.92	-	-
Net Cash Flow	4.33	-70.41	43.16	70.44	-37.61
Free Cash Flow	-31.12	-102.22	-187.95	-178.11	-100.61
Free Cash Flow Margin	-20.83%	-94.81%	-	-7822.31%	-827.14%
Free Cash Flow Per Share	-0.16	-0.53	-1.01	-1.03	-0.66
Cash Interest Paid	4.43	4.08	2.39	2.47	4
Levered Free Cash Flow	-4.34	-73.78	-68.9	-92.77	-
Unlevered Free Cash Flow	-1.57	-71.24	-67.4	-91.22	-
Change in Working Capital	-9.79	-9.79	-3.31	2.12	-11.55

Source: S&P Global Market Intelligence. Standard template. Financial Sources.